{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T21:08:35Z","timestamp":1775423315796,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.gore.2025.101932","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T23:37:17Z","timestamp":1756251437000},"page":"101932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): About three case reports"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8031-9112","authenticated-orcid":false,"given":"J.","family":"Benichou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Varinot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bossi-Croci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bazot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ferrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Dabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Darai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gore.2025.101932_b0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5858\/arpa.2022-0297-OA","article-title":"A population-based study of patients with small cell carcinoma of the ovary, hypercalcemic type, encompassing a 30-Year period","volume":"148","author":"Blatnik","year":"2024","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"8","key":"10.1016\/j.gore.2025.101932_b0010","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/S1470-2045(13)70088-3","article-title":"Extracranial rhabdoid tumours: what we have learned so far and future directions","volume":"14","author":"Brennan","year":"2013","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.gore.2025.101932_b0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2015.11.004","article-title":"Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): a review of 47 cases","volume":"140","author":"Callegaro-Filho","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.gore.2025.101932_b0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/his.12988","article-title":"Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics","volume":"69","author":"Clarke","year":"2016","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.gore.2025.101932_b0025","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/PAS.0000000000002296","article-title":"Additional considerations on aberrant BRG1 (SMARCA4) expression in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","volume":"48","author":"Cyrta","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"issue":"297","key":"10.1016\/j.gore.2025.101932_b0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejogrb.2024.04.001","article-title":"Immunotherapy combined with targeted therapy in advanced small cell carcinoma of the ovary of hypercalcemic type: a case of overall survival lasting for over 5 years","volume":"1","author":"Gao","year":"2024","journal-title":"Eur. J. Obst. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.gore.2025.101932_b0035","article-title":"Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma: a case series","volume":"53","author":"Glynn","year":"2024","journal-title":"Gynecol. Oncol. Rep."},{"issue":"5","key":"10.1016\/j.gore.2025.101932_b0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bjc.2017.228","article-title":"Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma","volume":"117","author":"Itamochi","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.gore.2025.101932_b0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.gore.2025.101932_b0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/modpathol.2015.129","article-title":"Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type","volume":"29","author":"Jelinic","year":"2016","journal-title":"Mod. Pathol."},{"issue":"7","key":"10.1016\/j.gore.2025.101932_b0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jnci\/djx277","article-title":"Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: rationale for immune checkpoint blockade","volume":"110","author":"Jelinic","year":"2018","journal-title":"J. Natl Cancer Inst."},{"issue":"3","key":"10.1016\/j.gore.2025.101932_b0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0020-7292(97)00238-5","article-title":"Prevalence of ovarian endometriosis in epithelial ovarian cancer","volume":"59","author":"Jimbo","year":"1997","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"9","key":"10.1016\/j.gore.2025.101932_b0065","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/PAS.0000000000000475","article-title":"SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas","volume":"39","author":"Karanian-Philippe","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.gore.2025.101932_b0070","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.gore.2025.101932_b0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5114\/pjp.2013.39331","article-title":"Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. A pilot study","volume":"64","author":"Kupryja\u0144czyk","year":"2013","journal-title":"Pol. J. Pathol."},{"key":"10.1016\/j.gore.2025.101932_b0080","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/PO.20.00063","article-title":"Combined CDK4\/6 and PD-1 inhibition in refractory SMARCA4-deficient small-cell carcinoma of the ovary hypercalcemic type","volume":"4","author":"Lee","year":"2020","journal-title":"JCO Precis Oncol."},{"issue":"32","key":"10.1016\/j.gore.2025.101932_b0085","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039226","article-title":"MR imaging diagnosis of small-cell carcinoma of the ovary, hypercalcemic type: a case report and literature review","volume":"103","author":"Li","year":"2024","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.gore.2025.101932_b0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jmg.33.4.333","article-title":"Familial cluster of ovarian small cell carcinoma: a new mendelian entity?","volume":"33","author":"Longy","year":"1996","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.gore.2025.101932_b0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.7150\/jca.26978","article-title":"An in-depth look at small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): clinical implications from recent molecular findings","volume":"10","author":"Lu","year":"2019","journal-title":"J. Cancer"},{"issue":"17","key":"10.1016\/j.gore.2025.101932_b0100","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3390\/cancers16173068","article-title":"Aberrant SWI\/SNF complex members are predominant in rare ovarian malignancies\u2014therapeutic vulnerabilities in treatment-resistant subtypes","volume":"16","author":"Ma","year":"2024","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.gore.2025.101932_b0105","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/1097-0142(19940401)73:7<1878::AID-CNCR2820730717>3.0.CO;2-D","article-title":"Human parathyroid hormone-related protein in ovarian small cell carcinoma an immunohistochemical study","volume":"73","author":"Matias-Guiu","year":"1994","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.gore.2025.101932_b0110","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/PAS.0000000000002088","article-title":"Unusual aspects of small cell carcinoma of the ovary of hypercalcaemic type: retained SMARCA4 immunohistochemical staining and positive staining with TLE1","volume":"47","author":"Mazibrada","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.gore.2025.101932_b0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gore.2017.09.010","article-title":"SMARCA4 germline gene mutation in a patient with epithelial ovarian: a case report","volume":"22","author":"Muppala","year":"2017","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.gore.2025.101932_b0120","article-title":"Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 ovarian cancer families: How young is too young?","volume":"32","author":"Podwika","year":"2020","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.gore.2025.101932_b0125","doi-asserted-by":"crossref","unstructured":"Qin Q, Ajewole VB, Sheu TG, Donohue R, Singh M. Successful treatment of a stage IIIC small-cell carcinoma of the ovary hypercalcemic subtype using multi-modality therapeutic approach [Internet]. 2018 [cited 2025 Jan 4]. Available from: http:\/\/ecancer.org\/en\/journal\/article\/832-successful-treatment-of-a-stage-iiic-small-cell-carcinoma-of-the-ovary-hypercalcemic-subtype-using-multi-modality-therapeutic-approach.","DOI":"10.3332\/ecancer.2018.832"},{"issue":"5","key":"10.1016\/j.gore.2025.101932_b0130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.gore.2025.101932_b0135","article-title":"Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","volume":"2","author":"Ramos","year":"2014","journal-title":"Rare Dis."},{"key":"10.1016\/j.gore.2025.101932_b0140","unstructured":"RJ K, ML C, CS H, RH Y. WHO Classification of Tumours of Female Reproductive Organs [Internet]. [cited 2021 Feb 18]. Available from: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/WHO-Classification-Of-Tumours-Of-Female-Reproductive-Organs-2014."},{"issue":"1","key":"10.1016\/j.gore.2025.101932_b0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1535-7163.MCT-20-0259","article-title":"Reprogramming of nucleotide metabolism mediates synergy between epigenetic therapy and MAP kinase inhibition","volume":"20","author":"Shorstova","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.gore.2025.101932_b0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/curroncol29020037","article-title":"Case report of small cell carcinoma of the ovary, hypercalcemic type (Ovarian Rhabdoid Tumor) with SMARCB1 mutation: a literature review of a rare and aggressive condition","volume":"29","author":"Sim\u00f5es","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.gore.2025.101932_b0155","unstructured":"Small Cell Carcinoma of the Ovary Hypercalcemic Type [Internet]. [cited 2025 Jan 4]. Available from: https:\/\/www.cincinnatichildrens.org\/health\/s\/sccoht."},{"issue":"15","key":"10.1016\/j.gore.2025.101932_b0160","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-cell carcinoma of the ovary, hypercalcemic type\u2013genetics, new treatment targets, and current management guidelines","volume":"26","author":"Tischkowitz","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.gore.2025.101932_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101287","article-title":"Using cancer phenotype sex-specificity to enable unbiased penetrance estimation of SMARCA4 pathogenic variants for small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","volume":"27","author":"Wade","year":"2025","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.gore.2025.101932_b0170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/path.4912","article-title":"The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type","volume":"242","author":"Wang","year":"2017","journal-title":"J. Pathol."},{"issue":"15","key":"10.1016\/j.gore.2025.101932_b0175","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.3390\/cancers15153794","article-title":"Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): patient characteristics, treatment, and outcome\u2014a systematic review","volume":"15","author":"Wens","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.gore.2025.101932_b0180","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.gore.2025.101932_b0185","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases","volume":"18","author":"Young","year":"1994","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925001572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578925001572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:08:57Z","timestamp":1761185337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578925001572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"alternative-id":["S2352578925001572"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101932","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): About three case reports","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101932"}}